Regulatory B cells in myasthenia gravis are differentially affected by therapies

We analyzed the number and functionality of regulatory B (Breg) cells in well‐defined myasthenia gravis patients. We first showed a decreased number of circulating CD19(+) CD24(++) CD38(++) Breg cells and an altered functionality of Breg cells in untreated myasthenia gravis patients. Next, we demons...

Descripción completa

Detalles Bibliográficos
Autores principales: Yilmaz, Vuslat, Maillard, Solène, Truffault, Frédérique, Bolgert, Francis, Behin, Anthony, Regnard, Jean‐François, Berrih‐Aknin, Sonia, Le Panse, Rozen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243377/
https://www.ncbi.nlm.nih.gov/pubmed/30480034
http://dx.doi.org/10.1002/acn3.645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6243377/
https://www.ncbi.nlm.nih.gov/pubmed/30480034
http://dx.doi.org/10.1002/acn3.645

Ejemplares similares